Keywords
Hepatectomy
Anesthesia
Postoperative complications
Clinical-epidemiological profile
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To characterize the clinical and epidemiological profile of patients undergoing elective hepatectomy and to evaluate the anesthetic strategies adopted at a reference hospital in Belém, Pará. Methods: Observational, retrospective, and descriptive study including patients who underwent elective hepatectomy (ICD-10: K76.9) between January 2022 and January 2025, through the review of electronic medical records. Results: The sample included 57 patients, with a balanced distribution between sexes and predominance of middle-aged and older adults. There was a prevalence of mixed-race, single individuals from inland areas. Most patients were classified as ASA II, denying smoking and alcohol consumption. Surgical time ranged from 160 to 259 minutes, with greater use of balanced general anesthesia associated with epidural anesthesia. Hematological and coagulational alterations were observed, highlighting the importance of rigorous preoperative monitoring. Postoperatively, 78.9% were referred to the ICU, and 31.6% presented complications. The most frequent comorbidities were cardiovascular and metabolic diseases, with a predominance of overweight and normal-weight patients. Conclusion: Patients showed a predominance of malignant diseases associated with cardiometabolic comorbidities, reflecting the regional epidemiological transition. Perioperative management demonstrated adherence to good anesthetic-surgical practices, emphasizing the need for structured optimization and postoperative monitoring protocols to achieve better clinical outcomes.
References
AMICO EC, et al. Complicações imediatas após 88 hepatectomias – série consecutiva brasileira. ABCD Arquivos Brasileiros de Cirurgia Digestiva, 2016; 3: 180-184.
CEDRO RM. O papel dos índices dos marcadores inflamatórios no prognóstico de pacientes com metástases hepáticas de câncer colorretal submetidos à ressecção hepática com intenção curativa. Dissertação (Mestrado em Ciências) – Faculdade de Medicina da Universidade de São Paulo, São Paulo, 2025.
CHEN F, et al. Impact of marital status on overall survival in patients with early-stage hepatocellular carcinoma. Scientific Reports, 2022; 12(1): 19923.
DE GASPERI A, et al. Major liver resections, perioperative issues and post-hepatectomy liver failure: a comprehensive update for the anesthesiologist. World Journal of Critical Care Medicine, 2024; 13(2): 92751.
DEVARBHAVI H, et al. Global burden of liver disease: 2023 update. Journal of Hepatology, 2023; 79(2): 516-537.
DIGGS LP, et al. Patient comorbidities drive high mortality rates associated with major liver resections irrespective of hospital volume. American Surgeon, 2021; 87(7): 1163–1170.
FODOR M, et al. Indications for liver surgery in benign tumours. European Surgery, 2018; 50(3): 125-131.
GARCIA FOB, et al. Hepatectomies: indications and results from a reference hospital in the Brazilian Amazon. Arquivos Brasileiros de Cirurgia Digestiva, 2024; 37: e1845.
GIUSTINIANO E, et al. Perioperative management of complex hepatectomy for colorectal liver metastases: the alliance between the surgeon and the anesthetist. Cancers (Basel), 2021; 13(9): 2203.
GUERRA MR, et al. Magnitude e variação da carga da mortalidade por câncer no Brasil e Unidades da Federação, 1990 e 2015. Revista Brasileira de Epidemiologia, 2017; 20(Suppl 01): 102-115.
GUIMARÃES JSF, et al. Burden of liver disease in Brazil, 1996-2022: a retrospective descriptive study of the epidemiology and impact on public healthcare. The Lancet Regional Health – Americas, 2024; 33: 100731.
HAYASHI H, et al. Combination of sarcopenia and prognostic nutritional index to predict long-term outcomes in patients undergoing initial hepatectomy for hepatocellular carcinoma. Asian Journal of Surgery, 2023; 46(2): 816–823.
KU GC, et al. Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality. HPB, 2022; 24(9): 1453–1463.
LE MH, et al. Prevalência global de NAFLD: uma revisão sistemática e meta-análise. Gastroenterologia e Hepatologia Clínica, 2022; 20(12): 2809–2817.e28.
MAGALHÃES CR, et al. Perfil clínico e epidemiológico do carcinoma hepatocelular no Brasil. Revista Foco, 2023; 16(3): e1388.
MARCUS SG, et al. Goal-directed therapy in liver surgery. Current Anesthesiology Reports, 2024; 14: 197–208.
MATTOS ÂA, et al. Perfil dos pacientes com diagnóstico de carcinoma hepatocelular acompanhados no ambulatório de nódulos hepáticos da Irmandade Santa Casa de Misericórdia de Porto Alegre. Revista AMRIGS, 2011; 55(3): 250–254.
NAGATA S, et al. Prognostic nutritional index considering resection range is useful for predicting postoperative morbidity of hepatectomy. Journal of Gastrointestinal Surgery, 2021; 25(11): 2788–2795.
PASCHOALOTTO CATUSSI MA, et al. Regionalização da saúde no Brasil: desigualdades socioeconômicas e na performance em saúde. Gestão & Regionalidade, 2022; 38(113): 313–327.
PATEL J, et al. Perioperative management for hepatic resection surgery. BJA Education, 2022; 22(9): 357–363.
PRIER CC, et al. Impact of religious affiliation on clinical outcomes in liver transplant patients. Cureus, 2024; 16(8): e66372.
RODRIGUES TFC, et al. Open, laparoscopic, and robotic-assisted hepatectomy in resection of liver tumors: a non-systematic review. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 2017; 30(2): 155–160.
SANTOS AA, et al. Metabolômica espacial e sua aplicação no fígado. Hepatology, 2024; 79(5): 1158-1179.
SILVA JUNIOR RF, et al. Perfil do câncer hepático e vias biliares intra-hepáticas em pacientes registrados no sistema Integrador dos Registros Hospitalares de Câncer do Instituto Nacional do Câncer. Cuadernos de Educación y Desarrollo, 2024; 16(1): 2952–2963.
SUNG H, et al. Estatísticas globais de câncer 2020: estimativas do GLOBOCAN de incidência e mortalidade em todo o mundo para 36 tipos de câncer em 185 países. CA: A Cancer Journal for Clinicians, 2021; 71(3): 209–249.
TEIXEIRA UF, et al. Enhanced Recovery (ERAS) After Liver Surgery: Comparative Study in a Brazilian Tertiary Center. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 2019; 32(1): e1424.
TOMMASO RP, et al. 10 anos de hepatectomias realizadas no Hospital Ophir Loyola. Brazilian Journal of Oncology, 2017; 13(S 01): 1-233.
VAGHIRI S, et al. Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study. Langenbecks Archives of Surgery, 2024; 409(1): 149.
VARGAS PA, et al. Surgical approach to achieve R0 resections in primary and metastatic liver tumors: a literature review. Journal of Gastrointestinal Oncology, 2023; 14(4): 1949-1958.
VIACAVA F, et al. Desigualdades regionais e sociais em saúde segundo inquéritos domiciliares (Brasil, 1998-2013). Ciência & Saúde Coletiva, 2019; 24(7): 2745–2760.
WHITE MJ, et al. A review of resection and surgical ablation for primary and secondary liver cancers. Seminars in Interventional Radiology, 2024; 40(6): 536-543.
ZANOTELLI ML, et al. Cirurgia hepática: experiência em 9 anos no Hospital de Clínicas de Porto Alegre. Revista HCPA, 2010; 1: 31-35.
ZHANG W, et al. Prognostic value of marital status on stage at diagnosis in hepatocellular carcinoma. Scientific Reports, 2017; 7: 41695.